文献速递肝病

肠道微生物群-脑-肝硬化轴

Gut microbiome-brain-cirrhosis axis.
PubMed 文献 · Hepatology · 2023-03-06

本文综述肝硬化的炎症、退变和纤维化特征及其与肝衰竭、肝移植和神经精神疾病的关系,重点讨论肠-肝-脑轴双向通讯及肠道微生物群在其中的关键作用,汇总临床与动物模型证据显示肝硬化时存在肠道菌群失调并影响认知与情绪行为,并总结调节肠道微生物群治疗肝硬化及相关神经精神疾病的现有证据。

要点

  • 肝硬化是肝衰竭和肝移植最常见原因,也是多种神经精神疾病的显著危险因素。
  • 肝性脑病以认知和共济失调症状为特征,源于肝衰竭时代谢毒素蓄积。
  • 肝硬化患者神经退行性疾病和情绪障碍风险显著增加。

核心结论

  • 肝硬化时肠道菌群失调影响认知和情绪相关行为,调节肠道微生物群可能是治疗肝硬化及相关神经精神疾病的手段。

研究设计与样本

  • 综述,总结临床和临床前研究中关于调节肠道微生物群治疗肝硬化及相关神经精神疾病的证据。

主要发现

  • 临床研究和动物模型显示肝硬化时存在显著肠道菌群失调,伴或不伴酒精使用障碍。
  • 肠道菌群失调也影响认知和情绪相关行为。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cirrhosis is characterized by inflammation, degeneration, and fibrosis of liver tissue. Along with being the most common cause of liver failure and liver transplant, cirrhosis is a significant risk factor for several neuropsychiatric conditions. The most common of these is HE, which is characterized by cognitive and ataxic symptoms, resulting from the buildup of metabolic toxins with liver failure. However, cirrhosis patients also show a significantly increased risk for neurodegenerative diseases such as Alzheimer and Parkinson diseases, and for mood disorders such as anxiety and depression. In recent years, more attention has been played to communication between the ways the gut and liver communicate with each other and with the central nervous system, and the way these organs influence each other's function. This bidirectional communication has come to be known as the gut-liver-brain axis. The gut microbiome has emerged as a key mechanism affecting gut-liver, gut-brain, and brain-liver communication. Clinical studies and animal models have demonstrated the significant patterns of gut dysbiosis when cirrhosis is present, both with or without concomitant alcohol use disorder, and have provided compelling evidence that this dysbiosis also influences the cognitive and mood-related behaviors. In this review, we have summarized the pathophysiological and cognitive effects associated with cirrhosis, links to cirrhosis-associated disruption of the gut microbiome, and the current evidence from clinical and preclinical studies for the modulation of the gut microbiome as a treatment for cirrhosis and associated neuropsychiatric conditions.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Smith ML, Wade JB, Wolstenholme J, et al. Gut microbiome-brain-cirrhosis axis. Hepatology. 2023. PMID: 36866864. doi:10.1097/HEP.0000000000000344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。